Your browser doesn't support javascript.
loading
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.
Lehn, Sophie; Tobin, Nicholas P; Sims, Andrew H; Stål, Olle; Jirström, Karin; Axelson, Håkan; Landberg, Göran.
Affiliation
  • Lehn S; Center for Molecular Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, 205 02 Malmö, Sweden. sophie.lehn@med.lu.se.
BMC Cancer ; 14: 119, 2014 Feb 22.
Article in En | MEDLINE | ID: mdl-24559095

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphoproteins / Tamoxifen / Breast Neoplasms / Gene Expression Regulation, Neoplastic / Antineoplastic Agents, Hormonal / Adaptor Proteins, Signal Transducing Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2014 Document type: Article Affiliation country: Sweden Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphoproteins / Tamoxifen / Breast Neoplasms / Gene Expression Regulation, Neoplastic / Antineoplastic Agents, Hormonal / Adaptor Proteins, Signal Transducing Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2014 Document type: Article Affiliation country: Sweden Country of publication: United kingdom